Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore the complex landscape of federal regulations governing molecular diagnostic testing and gene patenting in this 48-minute invited session from the Cancer Genomics Consortium. Examine the regulatory framework that impacts the development, validation, and commercialization of molecular diagnostic tests used in cancer genomics. Delve into the legal and regulatory challenges surrounding gene patenting, including recent court decisions and policy changes that have reshaped the intellectual property landscape in genomics. Learn about FDA oversight of diagnostic tests, CLIA regulations for laboratory testing, and the evolving regulatory environment for precision medicine applications. Understand how federal policies affect research institutions, diagnostic laboratories, and biotechnology companies working in the molecular diagnostics space. Gain insights into compliance requirements, regulatory pathways for test approval, and the implications of patent law changes on innovation and access to genetic testing technologies.
